Good Clinical Practice (GCP) | NIHR
2006
Good Clinical Practice (GCP) is the international ethical, scientific and practical standard to which all clinical research is conducted.
It is important that everyone involved in research is trained or appropriately experienced to perform the specific tasks they are being asked to undertake. GCP training is a requirement set out in the UK Policy Framework for Health and Social Care Research developed by the Health Research Authority for researchers conducting clinical trials of investigational medicinal products (CTIMPs).
Honorary Senior Researcher
2004
All terms and conditions for this contract extension remain as per the initial honorary contract issued to you on the 21st June 2004 by Hull University Teaching Hospitals NHS Trust.
Guest Editor of the Special Issue entitled "Cancer Associated Coagulation" in Hemato (ISSN 2673-6357)
2021
This Special Issue aims to encompass research in all aspects of cancer-associated coagulation, from understanding the mechanisms of tumour-driven hypercoagulopathy to advances in anticoagulant treatment and patient management. Certain tumours, such as those of the pancreas and ovaries, are associated with an increased risk of the patient developing venous thromboembolism and this risk increases further with chemotherapy by mechanisms currently being investigated. Patients are managed with the use of anticoagulants such as low-molecular-weight heparin or orally administered alternatives. Of particular interest is the role of extracellular vesicles within these processes and also research investigating the impact of COVID-19, although studies on all aspects of cancer-associated coagulation are welcome.
Associate Editor for Frontiers in Physiology: Clinical and Translational Physiology
2021
Hemato
2020
Hemato (ISSN 2673-6357) publishes regular research papers, reviews, letters and communications covering all aspects of hematology, from pathogenesis to diagnosis and personalized management, through in vivo genomic and immunologic research. Our aim is to improve the study of clinical and basic research of blood-related diseases. It covers topics related to hematopathology from laboratory to clinical studies, and the prevention, diagnosis, and therapeutics of hematological diseases, including components such as blood cells, blood proteins, blood vessels, bone marrow and coagulation. Furthermore, it encompasses topics related to all blood diseases, such as blood cancers, bleeding disorders, and hemophilia. There is no restriction on the length of the papers or colors used. The method/approach must be presented in detail so that the results can be reproduced. There are, in addition, three unique features of this journal:
Manuscripts regarding research proposals and research ideas are welcome
Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material
We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds
Disease Markers
2014
Disease Markers is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the identification of disease markers, the elucidation of their role and mechanism, as well as their application in the prognosis, diagnosis and treatment of diseases.